Clare V. Samuelson

Sheffield, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study.

Adult survivors of sickle cell disease, transfusion-dependent beta-thalassaemia and childhood acute leukaemia in England: protocol for a mixed methods data linkage and health-related quality of life survey study.

Journal: BMJ open
Published: February 02, 2026

Perinatal clinical management of a rare ABh variant blood group.

Perinatal clinical management of a rare ABh variant blood group.

Journal: Transfusion medicine (Oxford, England)
Published: January 08, 2025

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding.

High Prevalence of Platelet Function Disorders in Women Referred for Surgical Management of Refractory Heavy Menstrual Bleeding.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 06, 2024

CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United Kingdom.

CAnceR IN PreGnancy (CARING) - a retrospective study of cancer diagnosed during pregnancy in the United Kingdom.

Journal: British journal of cancer
Published: November 24, 2023

Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations.

Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations.

Journal: Molecular therapy. Methods & clinical development
Published: July 16, 2021

AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse.

AMD3100 redosing fails to repeatedly mobilize hematopoietic stem cells in the nonhuman primate and humanized mouse.

Journal: Experimental hematology
Published: August 22, 2020

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.

CRISPR/Cas9 for the treatment of haematological diseases: a journey from bacteria to the bedside.

Journal: British journal of haematology
Published: March 13, 2020

Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry.

Autologous haematopoietic stem cell transplantation (HSCT) for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: a retrospective survey of patients reported to European Society for Blood and Marrow Transplantation (EBMT) registry.

Journal: Bone marrow transplantation
Published: July 11, 2019

Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates.

Therapeutically relevant engraftment of a CRISPR-Cas9-edited HSC-enriched population with HbF reactivation in nonhuman primates.

Journal: Science translational medicine
Published: December 26, 2018

A daily topical decontamination regimen reduces catheter-related bloodstream infections in haematology patients.

A daily topical decontamination regimen reduces catheter-related bloodstream infections in haematology patients.

Journal: The Journal of infection
Published: June 22, 2017

High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies.

High prevalence of cardiovascular and respiratory abnormalities in advanced, intensively treated (transplanted) myeloma: The case for 'late effects' screening and preventive strategies.

Journal: Hematology (Amsterdam, Netherlands)
Published: April 15, 2016

Treatment of relapsed myelodysplastic syndrome following double umbilical cord blood transplantation with interferon alpha and 5-azacytidine.

Treatment of relapsed myelodysplastic syndrome following double umbilical cord blood transplantation with interferon alpha and 5-azacytidine.

Journal: British journal of haematology
Published: October 10, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026